In March, the FDA Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee unanimously voted to approve Cologuard, the stool-based DNA colorectal cancer screening test from ...
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences (Nasdaq: EXAS) issued the following statement today following the U.S. Preventive Services Task Force (USPSTF) draft recommendation statement for ...
Madison-based Exact Sciences says their at-home colorectal cancer kit Cologuard is being approved by the FDA for use in adults aged 45 and up. Previously, the test was only approved for people 50 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback